IPO Premiums
IPO calendar
PDListed

Par Drugs and Chemicals Limited

Fixed Price IPO · NSE

Price band
₹51 - ₹51
Lot size
2,000 shares
Issue amount
₹9 cr
Total subscription
0×
Current price₹164.95
Listing price ₹52.9
Watch live price ↗
Opens
3 May 2019
Closes
8 May 2019
Allotment
13 May 2019
Listing
16 May 2019

Offer at a glance

Issue overview

Issue size
16,72,000 shares
Face value
₹10 per share
Minimum investment
₹1,02,000
Fresh issue
₹0 cr
Offer for sale
₹0 cr
Registrar
Link Intime India Private Limited
Listing exchange
NSE
Maximum investment
₹1,02,000
Issue type
Fixed Price IPO
Shares before issue
44,80,318
Shares after issue
61,52,318

Lot sizes

CategoryLotsSharesAmount
RETAIL11₹1,02,000
HNI22₹2,04,000

Share reservation

Market Maker5.02%
HNI46.53%
RETAIL46.65%
Employee1.79%

Subscription & GMP

Subscription by category

Total subscribed0×

Subscription figures are awaiting publication.

GMP history

00.5126 Dec: ₹0
26 Dec₹026 Dec

Financial performance

Company financials

in Lakhs · Reported periods may include interim results.

Revenue & profitin Lakhs
02,0004,0006,000Mar-16 · Revenue: 3,326.43Mar-16 · Profit after tax: 42.18Mar-16Mar-17 · Revenue: 4,880.9Mar-17 · Profit after tax: 184.78Mar-17Mar-18 · Revenue: 4,241.65Mar-18 · Profit after tax: 149.53Mar-18Mar-19 · Revenue: 4,641.2Mar-19 · Profit after tax: 241.88Mar-19
RevenueProfit after tax

Company information

Company profile

Par Drugs and Chemicals Limited, incorporated in 1999 and based in Gujarat, is engaged in the manufacturing and development of active pharmaceutical ingredients (APIs) and fine chemicals for both domestic and international markets. Its APIs are used in tablets, capsules, and other finished dosages, and it also produces various antacid molecules. The company operates two manufacturing facilities in Ankleshwar and Bhavnagar, Gujarat, and offers a portfolio of 6 fine chemicals and 12 API products sold across 17 countries. Key customers include Dabur India Ltd, Meyer Organics Pvt. Ltd, Cadila Healthcare Ltd., Cipla Ltd, and Pfizer Ltd. For fiscal 2018, international sales accounted for 86.88% of total revenue, while domestic sales contributed 13.12%. The company maintains a testing laboratory to ensure quality standards and provides drying operations to convert liquid products into powders for its clients.

Strengths

  • Diversified Product Range: Offers a wide variety of products.
  • International Presence: Operates in global markets.
  • Efficient Distribution: Prompt and reliable sales and distribution network.
  • Proven Track Record: Established history of strong performance.
  • Strong Chemistry Capabilities: Expertise in chemical processes and development.

Promoters

Mr. Falgun Vallabhbhai Savani

Mr. Jignesh Vallabhbhai Savani

Registrar & documents

Lead manager

Pantomath Capital Advisor Private Limited

Registered office

805, Dwarkesh Complex, R.C. Dutt Road, Alkapuri, Vadodara-390 007,

+91 265 2332018

[email protected]Company website ↗

Frequently Asked Questions

What is Par Drugs and Chemicals IPO GMP today?

Currently, Par Drugs and Chemicals IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹51. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Par Drugs and Chemicals IPO?

The minimum bid lot size for Par Drugs and Chemicals IPO is 2,000 shares. At the cut-off price of ₹51 per share, retail investors need a minimum application amount of ₹1,02,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Par Drugs and Chemicals IPO allotment status be announced?

The allotment status for Par Drugs and Chemicals IPO is scheduled to be finalized on 13 May 2019. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Par Drugs and Chemicals IPO allotment status online by PAN?

To check Par Drugs and Chemicals IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Par Drugs and Chemicals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Par Drugs and Chemicals IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums